(Q36333755)

13 August 2017

1 reference

title

Crossed signals: oncogenic transcription factors. (English)

1 reference

13 August 2017

Forrest D

1

1 reference

PubMed ID

1633422

13 August 2017

Curran T

series ordinal

2

1 reference

13 August 2017

1 February 1992

1 reference

Current Opinion in Genetics & Development

13 August 2017

1 reference

13 August 2017

2

1 reference

13 August 2017

19-27

1 reference

13 August 2017

1

1 reference

Protein encoded by v-erbA functions as a thyroid-hormone receptor antagonist

13 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Repression of transcription mediated at a thyroid hormone response element by the v-erb-A oncogene product

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Ontogeny of the v-erbA oncoprotein from the thyroid hormone receptor: an alteration in the DNA binding domain plays a role crucial for v-erbA function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

v-erbA Oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Positive and negative regulation of gene transcription by a retinoic acid-thyroid hormone receptor heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

A novel mechanism of action for v-ErbA: abrogation of the inactivation of transcription factor AP-1 by retinoic acid and thyroid hormone receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Phosphorylation of the v-erbA protein is required for its function as an oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Transcriptional regulation by Fos and Jun in vitro: interaction among multiple activator and regulatory domains

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Fos-Jun heterodimers and Jun homodimers bend DNA in opposite orientations: implications for transcription factor cooperativity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Ha-Ras augments c-Jun activity and stimulates phosphorylation of its activation domain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Phosphorylation of c-jun mediated by MAP kinases.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Transformation suppressor activity of a Jun transcription factor lacking its activation domain

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

v-Src and EJ Ras alleviate repression of c-Jun by a cell-specific inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Activation of protein kinase C decreases phosphorylation of c-Jun at sites that negatively regulate its DNA-binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Redox regulation of fos and jun DNA-binding activity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Activation of the transforming potential of the human fos proto-oncogene requires message stabilization and results in increased amounts of partially modified fos protein

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Nuclear localization of c-Fos, but not v-Fos proteins, is controlled by extracellular signals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Efficient transformation of chicken embryo fibroblasts by c-Jun requires structural modification in coding and noncoding sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

NF-kappa B, KBF1, dorsal, and related matters

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Activation in vitro of NF-kappa B by phosphorylation of its inhibitor I kappa B

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Rel-associated pp40: an inhibitor of the rel family of transcription factors

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

The v-rel oncogene encodes a kappa B enhancer binding protein that inhibits NF-kappa B function

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

vRel is an inactive member of the Rel family of transcriptional activating proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

Fusion of the nuclear oncoproteins v-Myb and v-Ets is required for the leukemogenicity of E26 virus

1 reference

https://api.crossref.org/works/10.1016%2FS0959-437X%2805%2980316-8

7 January 2021

10.1016/S0959-437X(05)80316-8

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

1633422